22 May 2013
Keywords: enzon, pharma, explores, options, including, sale, its
Article | 18 August 2008
US firm Enzon Pharmaceuticals pleased investors, by revealing that it is exploring strategic alternatives for its specialty drugs business, which
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2008
21 May 2013
© 2013 thepharmaletter.com